glembatumumab vedotin

Ligand id: 8926

Name: glembatumumab vedotin

References
1. Kuan CT, Wakiya K, Dowell JM, Herndon 2nd JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD. (2006)
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Clin. Cancer Res., 12 (7 Pt 1): 1970-82. [PMID:16609006]
2. Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M et al.. (2010)
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Clin. Cancer Res., 16 (7): 2147-56. [PMID:20215530]
3. Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM. (2007)
Osteoactivin promotes breast cancer metastasis to bone.
Mol. Cancer Res., 5 (10): 1001-14. [PMID:17951401]
4. Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL et al.. (2006)
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Clin. Cancer Res., 12 (4): 1373-82. [PMID:16489096]